Anti-asthmatic potential of chrysin on ovalbumin-induced bronchoalveolar hyperresponsiveness in rats

Pharmaceutical Biology

Volumn 49, Issue 5, 2011, Pages 508-515

  Wadibhasme, Pankaj G ^a   Ghaisas, Mahesh M ^b   Thakurdesai, Prasad A ^c  

^a DR D Y PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b Indira College of Pharmacy   (India)

^c Indus Biotech Private Limited   (India)

Author keywords

antioxidant; asthma; Chrysin; flavonoid; ovalbumin hyperresponsiveness

Indexed keywords

ALKALINE PHOSPHATASE; CHRYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; NITRIC OXIDE SYNTHASE; NITRITE; OVALBUMIN; TRANSCRIPTION FACTOR AP 1;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; DRUG TARGETING; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG INJURY; LUNG LAVAGE; MACROPHAGE ACTIVATION; NONHUMAN; POLARIZATION; RAT; SCORING SYSTEM; TH1 CELL; TH2 CELL;

ANIMALS; ANTI-ASTHMATIC AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL POLARITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; LUNG; ORGAN SIZE; OVALBUMIN; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS;

EID: 79955062148     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.521754     Document Type: Article

References (38)

1. Burdock GA. (1998). Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol, 36, 347-363. (Pubitemid 28255348)
2. Chapman RW, House A, Jones H, Richard J, Celly C, Prelusky D, Ting P, Hunter JC, Lamca J, Phillips JE. (2007). Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats. Eur J Pharmacol, 571, 215-221. (Pubitemid 47385896)
3. Chen CY, Peng WH, Tsai KD, Hsu SL. (2007). Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci, 81, 1602-1614.
4. Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, Lee S, Kim BK. (2004). Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res, 49, 37-43. (Pubitemid 37324901)
5. Choi JR, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH, Park HJ, Choi IW, Kim JS, Shin YK, Park SN, Park YM. (2009). Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 gene. Int Immunopharmacol, 9, 918-924.
6. Comalada M, Ballester I, Bailón E, Sierra S, Xaus J, Gálvez J, de Medina FS, Zarzuelo A. (2006). Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship. Biochem Pharmacol, 72, 1010-1021. (Pubitemid 44374465)
7. Das M, Ram A, Ghosh B. (2003). Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice. Inflamm Res, 52, 101-106. (Pubitemid 36470069)
8. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. (1993). A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med, 15, 353-363. (Pubitemid 23283552)
9. Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. (1996). Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J, 9, 1736-1742. (Pubitemid 26271162)
10. Epstein MM. (2006). Targeting memory Th2 cells for the treatment of allergic asthma. Pharmacol Ther, 109, 107-136. (Pubitemid 41742235)
11. Eynott PR, Groneberg DA, Caramori G, Adcock IM, Donnelly LE, Kharitonov S, Barnes PJ, Chung KF. (2002). Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur J Pharmacol, 452, 123-133. (Pubitemid 35248132)
12. Fu B, Xue J, Li Z, Shi X, Jiang BH, Fang J. (2007). Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol Cancer Ther, 6, 220-226. (Pubitemid 46206685)
13. Greene LS. (1995). Asthma and oxidant stress: nutritional, environmental, and genetic risk factors. J Am Coll Nutr, 14, 317-324.
14. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. (2006). Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr, 136, 1517-1521. (Pubitemid 43765355)
15. Henricks PA, Nijkamp FP. (2001). Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther, 14, 409-420.
16. Hougee S, Sanders A, Faber J, Graus YM, van den Berg WB, Garssen J, Smit HF, Hoijer MA. (2005). Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol, 69, 241-248. (Pubitemid 41556570)
17. Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, Lin JK. (2001). Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett, 496, 12-18.
18. Maden M, Altunok V, Birdane FM, Aslan V, Nizamlioglu M. (2001). Specific enzyme activities in bronchoalveolar lavage fluid as an aid to diagnosis of tracheobronchitis and bronchopneumonia in dogs. Res Vet Sci, 71, 141-145. (Pubitemid 33100073)
19. Mathew JE, Srinivasan KK, Dinakaran V, Joseph A. (2009). Mast cell stabilizing effects of Sphaeranthus indicus. J Ethnopharmacol, 122, 394-396.
20. Medina JH, Paladini AC, Wolfman C, Levi de Stein M, Calvo D, Diaz LE, Pena C. (1990). Chrysin (5,7-di-OH-flavone), a naturallyoccurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem Pharmacol, 40, 2227-2231. (Pubitemid 20373980)
21. Middleton E Jr, Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev, 52, 673-751.
22. Montoro P, Carbone V, Pizza C. (2005). Flavonoids from the leaves of Cyclanthera pedata: Two new malonyl derivatives. Phytochem Anal, 16, 210-216. (Pubitemid 40903227)
23. Nevin BJ, Broadley KJ. (2002). Nitric oxide in respiratory diseases. Pharmacol Ther, 95, 259-293. (Pubitemid 35247904)
24. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, Williamson G. (2004). Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res, 551, 245-254. (Pubitemid 38833512)
25. Packard KA, Khan MM. (2003). Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol, 3, 909-920. (Pubitemid 36700444)
26. Park EJ, Cho WS, Jeong J, Yi J, Choi K, Park K. (2009). Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology, 259, 113-121.
27. Portela Cde P, Massoco Cde O, de Lima WT, Palermo-Neto J. (2001). Stress-induced increment on total bronchoalveolar cell count in OVA-sensitized rats. Physiol Behav, 72, 415-420. (Pubitemid 32234429)
28. Rahman A, Kang S. (2009). In vitro control of food-borne and food spoilage bacteria by essential oil and ethanol extracts of Lonicera japonica Thunb. Food Chem, 116, 670-675.
29. Rahman I, Biswas SK, Kode A. (2006). Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol, 533, 222-239. (Pubitemid 43340015)
30. Rogerio AP, Kanashiro A, Fontanari C, da Silva EV, Lucisano-Valim YM, Soares EG, Faccioli LH. (2007). Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res, 56, 402-408. (Pubitemid 350160416)
31. Sanjar S, Aoki S, Kristersson A, Smith D, Morley J. (1990). Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: The effect of anti-asthma drugs. Br J Pharmacol, 99, 679-686. (Pubitemid 20111306)
32. Shakib F, Ghaemmaghami AM, Sewell HF. (2008). The molecular basis of allergenicity. Trends Immunol, 29, 633-642.
33. Smith N, Broadley KJ. (2007). Optimisation of the sensitisation conditions for an ovalbumin challenge model of asthma. Int Immunopharmacol, 7, 183-190. (Pubitemid 46037557)
34. Verstraelen S, Bloemen K, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. (2008). Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol in Vitro, 22, 1419-1431.
35. Ward JE, Fernandes DJ, Taylor CC, Bonacci JV, Quan L, Stewart AG. (2006). The PPARgamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation. Pulm Pharmacol Ther, 19, 39-46. (Pubitemid 41606851)
36. Woo KJ, Jeong YJ, Inoue H, Park JW, Kwon TK. (2005). Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS Lett, 579, 705-711.
37. Wright JR, Colby HD, Miles PR. (1981). Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys, 206, 296-304. (Pubitemid 11102033)
38. Yano S, Umeda D, Yamashita T, Ninomiya Y, Sumida M, Fujimura Y, Yamada K, Tachibana H. (2007). Dietary flavones suppresses IgE and Th2 cytokines in OVA-immunized BALB/c mice. Eur J Nutr, 46, 257-263. (Pubitemid 47125265)